Jefferies Reiterates Buy Rating on Legend Biotech Corp. (LEGN)

March 10, 2026 12:01 PM

Jefferies analyst Cui Cui reiterated a Buy rating and $69.00 price target on Legend Biotech Corp. (NASDAQ: LEGN)The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found